ACHF_Donate DONATE NOW

Protecting Students from MenB: A Partnership with Pfizer

Materials for Sharing with Students

ACHF, in partnership with Pfizer, has developed a digital brochure to be shared with students to help educate them on the causes, symptoms, and spread of serogroup B meningococcal disease (MenB). The brochure also highlights prevention of MenB through vaccination and the rates of MenB compared to other serogroups. Available materials include a PDF version as well as images to be shared on a campus website or through social media accounts.

This brochure can be posted directly on your campus health center website as either an image or a PDF, or shared on social media platforms.

Please visit the ACHA Store to download a zip file that includes the following:

  • A PDF for printing or posting as link on a website
  • An image for web posting (a PNG for posting as an image on a website) 
  • Social media-optimized images (PNGs for sharing on social media sites)

References

1Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397-403.

2Centers for Disease Control and Prevention. Meningococcal disease. Centers for Disease Control and Prevention website. https://www.cdc.gov-
/meningococcal/about/symptoms.html. Updated June 7, 2017.

3Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications
for prevention of meningococcal disease. Clin Infect Dis. 2010;50(2):184-191.

4Bettinger JA, Scheifele DW, Le Saux N, et al. The disease burden of invasive meningococcal serogroup B disease in Canada. Pediatr Infect Dis J.
2013;32(1):e20-e25.

5Borg J, Christie D, Coen PG, et al. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics.
2009;123:e502-e509.

6Centers for Disease Control and Prevention. Meningococcal surveillance. Centers for Disease Control and Prevention website.
https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2017.pdf

7Meyer S. Epidemiology of meningococcal disease among college students – United States, 2014-2016. ACIP. February 2018.
https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2018-02/Mening-02-Meyer-508.pdf

8Christensen H, May M, Bowen L, et al. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis.
2010;10(12):853-861.

9World Health Organization. http://www.who.int/mediacentre/factsheets/fs141/en/. Reviewed January 2018.

10Tully J, Viner RM, Coen PG, et al. Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ.
2006;332(7539):445-450.

11Dwillow R and Fanella S. Invasive meningococcal disease in the 21st century—an update for the clinician. Curr Neurol Neurosci Rep.
2015;15(2):1-9.

12MacNeil JR, Rubin L, Folaranmi T, et al. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the
Advisory Committee on Immunization Practices, 2015. MMWR. 2015;64(41):1171-1176.